Ranitidine safety alert: DCGI should have put the drug on temporary hold till it had been certified safe |
Editorial
eMediNexus Coverage from: 
Ranitidine safety alert: DCGI should have put the drug on temporary hold till it had been certified safe

10 Read Comments                

Vide a notification F. No. 12-03/19/DC (Safety-007), the DCGI has issued a directive to all the States and UT Drug controllers regarding a nitrosamine impurity, N-nitrosodimethylamine (NDMA) in ranitidine.Ranitidine is an OTC drug. It is also one of the most commonly prescribed drugs for heartburn and GERD.The DCGI has asked all Drug controllers of states and UTs to communicate to the manufacturers of ranitidine API & formulations under their jurisdiction “to verify their products...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now